Although we reported a difference in the frequency of TB-specific IFN-γ+CD38+ and IFN-γ+HLA-DR+ CD4+ T cells in the TB/HCV group, we did not observe an association between the frequency of these cells and the outcome of infection or response to anti-TB therapy. Here, CD38 is linked to infection.